| Tue, Sep 15, 2009 | | • | StockPreacher.com Issues Technical Trading Overview for StemCells Inc.
GlobeNewswire (Tue, Sep 15)
| | Mon, Sep 14, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Sep 14)
| | • | Aastrom Biosciences Reports Fourth Quarter and Fiscal Year 2009 Financial Results
GlobeNewswire (Mon, Sep 14)
| | Tue, Sep 8, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Fina
EDGAR Online (Tue, Sep 8)
| | Thu, Sep 3, 2009 | | • | Aastrom Announces Transitions in Senior Management
GlobeNewswire (Thu, Sep 3)
| | Mon, Aug 10, 2009 | | • | Compassionate Use Patients in Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants
GlobeNewswire (Mon, Aug 10)
| | Mon, Aug 3, 2009 | | • | Aastrom Biosciences to Present At BMO Capital Markets Healthcare Conference
GlobeNewswire (Mon, Aug 3)
| | Tue, Jul 14, 2009 | | • | Aastrom Biosciences Receives Notification That NASDAQ to Continue Temporary Suspension of Certain Continued Listing Requirements
GlobeNewswire (Tue, Jul 14)
| | Thu, Jun 18, 2009 | | • | FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
GlobeNewswire (Thu, Jun 18)
| | Fri, Jun 12, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S
EDGAR Online (Fri, Jun 12)
| | Wed, May 27, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and
EDGAR Online (Wed, May 27)
| | Fri, May 22, 2009 | | • | Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
GlobeNewswire (Fri, May 22)
| | Fri, May 8, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, May 8)
| | • | Aastrom Reports Third Quarter Fiscal Year 2009 Financial Results
GlobeNewswire (Fri, May 8)
| | Tue, May 5, 2009 | | • | Initial Data From Aastrom's IMPACT-DCM Trial Presented At International Society for Cellular Therapy Annual Meeting by Amit N. Patel, M.D.
GlobeNewswire (Tue, May 5)
| | Mon, Mar 23, 2009 | | • | Aastrom Biosciences Receives Notification That NASDAQ Further Extends Suspension of Certain Continued Listing Requirements
GlobeNewswire (Mon, Mar 23)
| | Wed, Mar 11, 2009 | | • | Geron Stem Cell Trial Risky, Doctors Warn
at TheStreet.com (Wed, Mar 11)
| | Tue, Mar 10, 2009 | | • | Aastrom Commends Expansion of Federal Support for Stem Cell Research
GlobeNewswire (Tue, Mar 10)
| | Fri, Mar 6, 2009 | | • | Why We Love Wild Penny Stocks ... in a Recession
at Motley Fool (Fri, Mar 6)
| | • | Why We Love Wild Penny Stocks ... in a Recession
at Motley Fool (Fri, Mar 6)
| | Tue, Mar 3, 2009 | | • | FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
GlobeNewswire (Tue, Mar 3)
| | • | FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
GlobeNewswire (Tue, Mar 3)
| | Thu, Feb 19, 2009 | | • | Stem Cell Mad-ness
at Investopedia (Thu, Feb 19)
| | Wed, Feb 18, 2009 | | • | Geron Short Closed After Latest Drop
at TheStreet.com (Wed, Feb 18)
| | Wed, Feb 11, 2009 | | • | Irrational Exuberance, Part II
at Investopedia (Wed, Feb 11)
|
Add ASTM News to My Yahoo!:
 
| |
|
0.02% Nasdaq 
Headlines
